Correction: Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncted Abeta in sporadic Alzheimer disease cases and mouse models
2024 | journal article; erratum. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
Correction: Abeta targets of the biosimilar antibodies of Bapineuzumab, Crenezumab, Solanezumab in comparison to an antibody against N-truncted Abeta in sporadic Alzheimer disease cases and mouse models
Bouter, Y.; Noguerola, J. S. L.; Tucholla, P.; Crespi, G. A. N.; Parker, M. W.; Wiltfang, J. & Miles, L. A. et al. (2024)
Acta Neuropathologica, 147(1). DOI: https://doi.org/10.1007/s00401-024-02718-w
